00925nam0-22003011i-450-990003705050403321200010100521460549000370505FED01000370505(Aleph)000370505FED0100037050520000920d1994----km-y0itay50------baitay-------001yyInternational capital markets and American economic growth, 1820-1914Lance E. Davis [and] Robert J. CullCambridgeCambridge University Press1994VII, 166 p.24 cmDavis,Lance Edwin<1928- >118703Cull,Robert J.ITUNINARICAUNIMARCBK990003705050403321N2.3176380DECTSDECTSInternational capital markets and American economic growth, 1820-1914500886UNINAING0101007cam0 22002771 450 SOBE0002615820120614090248.020120614d1979 |||||ita|0103 baengGBNews From Nowhere or an epoch of restbeing some chapters from a utopian romanceby William Morrisedited by James RedmondLondonRoutledge and Kegan Paul1979XLII, 194 p.19 cmRoutledge English texts001LAEC000209622001 *Routledge English textsMorris, WilliamSOBA00001819070329529Redmond, JamesSOBA00002453070ITUNISOB20120614RICAUNISOBUNISOB82031376SOBE00026158M 102 Monografia moderna SBNM820000577SI31376rovitoUNISOBUNISOB20120614085023.020120614085039.0rovitoNews from nowhere, or An epoch of rest217526UNISOB03967nam 2200985z- 450 991056646590332120220506(CKB)5680000000037721(oapen)https://directory.doabooks.org/handle/20.500.12854/81062(oapen)doab81062(EXLCZ)99568000000003772120202205d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierNeuromuscular Disorders in Children and AdolescentsBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (146 p.)3-0365-4070-9 3-0365-4069-5 Significant scientific and therapeutic advances have been made in recent decades, particularly in hereditary but also in acquired neuromuscular diseases. As a result of our increasing etiological understanding, the classification of these diseases has changed from a clinical-descriptive and formal-genetic to a molecular-genetic and pathophysiological one. This has led to an intensification of research into the diagnosis and treatment of these diseases, resulting in the first effective gene-modifying treatments for DMD and SMA in recent years and, more recently, gene replacement therapy for the most severe form of SMA. In addition, great strides have been made in symptomatic and rehabilitative treatment, making it possible to improve the functioning and quality of life of those affected and their families. This Special Issue of Children contains a collection of 12 studies and reviews dealing with genetic and acquired peripheral nerve and muscle disorders.Medicine and NursingbicsscNeurology and clinical neurophysiologybicssc3-hydroxy-3-methylglutaryladolescentsAMCbrachial plexus neuritiscarpal tunnel syndromecarrier frequencychaperone-assisted autophagyCharcot-Marie-Tooth diseasechild neurologychildrenclinical courseclinical trialscoenzyme A reductasecontracturesdistal arthrogryposisDuchenne muscular dystrophyECEL1electrodiagnostic studiesfine manual dexterityGAA genegeneral population databasegenetic prevalencehereditary sensory and motor neuropathyinflammatory neuropathyjuvenile myositiskyphosismedian nerve neuropathymetabolic neuropathymucopolysaccharidosismusclemuscle MRIn/aneuromuscularneuromuscular diseaseneuromuscular ultrasoundneuropathynusinersenparalysispatient-reported outcomespediatricsPompe diseaseposterior spinal fusionpublic health surveillancequality of lifesagittal plane deformitysignal recognition particlespinal muscular atrophyspinal muscular atrophy (SMA)therapytraumatic neuropathyultrasonographic elastographyvaccinationMedicine and NursingNeurology and clinical neurophysiologyKorinthenberg Rudolfedt1319552Korinthenberg RudolfothBOOK9910566465903321Neuromuscular Disorders in Children and Adolescents3033957UNINA